George C. Petrocheilos
Gründer bei Catalio Capital Management LP
Profil
George C.
Petrocheilos is the founder and currently holds director positions at MindX, Sisu Global Health, LifeSprout, Mind-X Corp., Haystack Oncology, and is a trustee at Kennedy Krieger Institute.
He previously held director positions at WindMIL Therapeutics and Spiral Therapeutics.
Petrocheilos was a partner at Camden Partners Private Equity from 2015 to 2020 and was the president of HealthCor Catalio Acquisition Corp.
Petrocheilos graduated from The Johns Hopkins University in 2013 with an undergraduate degree and also attended Harvard University for graduate studies.
Aktive Positionen von George C. Petrocheilos
Unternehmen | Position | Beginn |
---|---|---|
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Gründer | 01.06.2020 |
MindX
MindX Packaged SoftwareTechnology Services MindX engages in developing games. The company is headquartered in United State. | Direktor/Vorstandsmitglied | - |
Sisu Global Health, Inc.
Sisu Global Health, Inc. BiotechnologyHealth Technology Sisu Global Health develops commercially scales and medical products. Its Hemafuse is a handheld, mechanical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations. The company was founded by Carolyn Reed Yarina, Gillian Henker and Katie Kirsch and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | - |
LifeSprout, Inc.
LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | - |
Kennedy Krieger Institute, Inc.
Kennedy Krieger Institute, Inc. Medical/Nursing ServicesHealth Services Kennedy Krieger Institute, Inc. provides services for children with developmental concerns mild to severe. Its services include patient care, research initiatives, special education, professional training, and community initiatives. The firm specializes in autism spectrum disorders, behavior disorders, brain injury, cerebral palsy, communication disorders, down syndrome, and sleep disorders. The company was founded in 1937 and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | - |
Mind-X Corp.
Mind-X Corp. Packaged SoftwareTechnology Services Mind-X Corp. designs and develops software application. The firm offers MindX. The company was founded by R. Jacob Vogelstein, Julia Brown, and Emily Caporello Bluvas in 2017 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
Haystack Oncology, Inc.
Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Part of Quest Diagnostics, Inc., Haystack Oncology, Inc. is a biopharmaceutical company based in Baltimore, MD. The Haystack MRD test is CLIA certified in the US and is available for biopharmaceutical clinical development in laboratories located in various locations. The company developed Haystack MRD™, a next-generation tumor-informed approach for the measurement of minimal residual disease. Haystack Oncology works with biopharmaceutical companies to advance important therapeutics to markets, from early phase clinical development to companion diagnostics. The test accelerates clinical development with better MRD testing unmatched sensitivity and specificity for confident MRD detection. The company leverages unmatched sensitivity and specificity to accelerate clinical trials and produce insights that drive biopharma pipeline development. The company was founded in 2021 by Kenneth W. Kinzler, Nickolas Papadopoulos, Joshua Cohen, Bert Vogelstein, and the CEO is Dan Edelstein. Haystack Oncology was acquired by Quest Diagnostics, Inc. on June 21, 2023 for $450 million. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von George C. Petrocheilos
Unternehmen | Position | Ende |
---|---|---|
Camden Partners Private Equity
Camden Partners Private Equity Investment ManagersFinance Camden Partners Private Equity (Camden Partners) is a private equity subsidiary of Camden Partners Holdings LLC founded in 1995 by David Lyle Warnock. The firm is headquartered in Baltimore, Maryland. | Private Equity Investor | 01.06.2020 |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Direktor/Vorstandsmitglied | - |
░░░░ ░░░░ | ░░░░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von George C. Petrocheilos
Harvard University | Graduate Degree |
The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 11 |
---|---|
MindX
MindX Packaged SoftwareTechnology Services MindX engages in developing games. The company is headquartered in United State. | Technology Services |
Kennedy Krieger Institute, Inc.
Kennedy Krieger Institute, Inc. Medical/Nursing ServicesHealth Services Kennedy Krieger Institute, Inc. provides services for children with developmental concerns mild to severe. Its services include patient care, research initiatives, special education, professional training, and community initiatives. The firm specializes in autism spectrum disorders, behavior disorders, brain injury, cerebral palsy, communication disorders, down syndrome, and sleep disorders. The company was founded in 1937 and is headquartered in Baltimore, MD. | Health Services |
Camden Partners Private Equity
Camden Partners Private Equity Investment ManagersFinance Camden Partners Private Equity (Camden Partners) is a private equity subsidiary of Camden Partners Holdings LLC founded in 1995 by David Lyle Warnock. The firm is headquartered in Baltimore, Maryland. | Finance |
Sisu Global Health, Inc.
Sisu Global Health, Inc. BiotechnologyHealth Technology Sisu Global Health develops commercially scales and medical products. Its Hemafuse is a handheld, mechanical device for intraoperative autotransfusion of blood collected from an internal hemorrhage, meant to replace or augment donor blood in emergency situations. The company was founded by Carolyn Reed Yarina, Gillian Henker and Katie Kirsch and is headquartered in Baltimore, MD. | Health Technology |
WindMIL Therapeutics, Inc.
WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Health Technology |
LifeSprout, Inc.
LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Health Technology |
Mind-X Corp.
Mind-X Corp. Packaged SoftwareTechnology Services Mind-X Corp. designs and develops software application. The firm offers MindX. The company was founded by R. Jacob Vogelstein, Julia Brown, and Emily Caporello Bluvas in 2017 and is headquartered in Bethesda, MD. | Technology Services |
Spiral Therapeutics, Inc.
Spiral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Spiral Therapeutics, Inc. manufactures pharmaceutical products. The firm also develops therapies for inner ear disorders. The company was founded by Hugo Peris, Justin S. Hanes and Eugene de Juan in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
HealthCor Catalio Acquisition Corp.
HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance HealthCor Catalio Acquisition Corp. operates as a Cayman Islands exempted company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on November 18, 2020 and is headquartered in New York, NY. | Finance |
Haystack Oncology, Inc.
Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Part of Quest Diagnostics, Inc., Haystack Oncology, Inc. is a biopharmaceutical company based in Baltimore, MD. The Haystack MRD test is CLIA certified in the US and is available for biopharmaceutical clinical development in laboratories located in various locations. The company developed Haystack MRD™, a next-generation tumor-informed approach for the measurement of minimal residual disease. Haystack Oncology works with biopharmaceutical companies to advance important therapeutics to markets, from early phase clinical development to companion diagnostics. The test accelerates clinical development with better MRD testing unmatched sensitivity and specificity for confident MRD detection. The company leverages unmatched sensitivity and specificity to accelerate clinical trials and produce insights that drive biopharma pipeline development. The company was founded in 2021 by Kenneth W. Kinzler, Nickolas Papadopoulos, Joshua Cohen, Bert Vogelstein, and the CEO is Dan Edelstein. Haystack Oncology was acquired by Quest Diagnostics, Inc. on June 21, 2023 for $450 million. | Health Services |